Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Large Cap

Large Cap

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • ETFs
  • Eurozone
  • Global
  • Large Cap
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Top Stories
  • Trading Ideas

US Financial Stocks Plummet On Fears of Contagion After Deutsche Bank Selloff

By Piero Cingari
March 24, 11:54 AM
U.S. bank stocks were taking a heavy hit in Friday trading following the sharp pullback in European financial equities, dragged down by the sell-off in Deutsche Bank (NYSE: DB).

BAC

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • Large Cap
  • Movers
  • News
  • Trading Ideas

Second Setback For Incyte’s LIMBER Program – Analyst Says ‘Resolution Timelines Unclear To Assess Impact’

By Vandana Singh
March 24, 11:28 AM
The FDA issued a complete response letter (CRL) to Incyte Corporation (NASDAQ:INCY) ruxolitinib extended-release (XR) tablets, a JAK1/JAK2 inhibitor, for once-daily (QD)…

INCY

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • Large Cap
  • Movers
  • News
  • Trading Ideas

Second Setback For Incyte’s LIMBER Program – Analyst Says ‘Resolution Timelines Unclear To Assess Impact’

By Vandana Singh
March 24, 11:28 AM
The FDA issued a complete response letter (CRL) to Incyte Corporation (NASDAQ:INCY) ruxolitinib extended-release (XR) tablets, a JAK1/JAK2 inhibitor, for once-daily (QD)…

INCY

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Downgrades
  • General
  • Large Cap
  • News
  • Price Target
  • Topics
  • Trading Ideas

Charles Schwab Shares Down 32% In March, Analysts Still See ‘Downside To Valuation’

By AJ Fabino
March 24, 11:27 AM
Analysts at Bank of America Global Research are well-aware that shares of Charles Schwab Corporation (NYSE: SCHW) are down 35% this year amid the regional banking debacle, and they see further downside to its valuation: here’s why.

SCHW

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Downgrades
  • General
  • Large Cap
  • News
  • Price Target
  • Topics
  • Trading Ideas

Charles Schwab Shares Down 32% In March, Analysts Still See ‘Downside To Valuation’

By AJ Fabino
March 24, 11:27 AM
Analysts at Bank of America Global Research are well-aware that shares of Charles Schwab Corporation (NYSE: SCHW) are down 35% this year amid the regional banking debacle, and they see further downside to its valuation: here’s why.

SCHW

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Downgrades
  • General
  • Large Cap
  • News
  • Price Target
  • Topics
  • Trading Ideas

Charles Schwab Shares Down 32% In March, Analysts Still See ‘Downside To Valuation’

By AJ Fabino
March 24, 11:27 AM
Analysts at Bank of America Global Research are well-aware that shares of Charles Schwab Corporation (NYSE: SCHW) are down 35% this year amid the regional banking debacle, and they see further downside to its valuation: here’s why.

SCHW

Read More
1 minute read
  • General
  • Health Care
  • Large Cap
  • News

Juul Is Divested – Altria Now Focuses On Development Efforts For Smoke-Free Products, Updates 2028 Goals

By Vandana Singh
March 24, 11:24 AM
Altria Group Inc (NYSE: MO) unveils a lineup of e-cigarettes, oral nicotine pouches, and other smoke-free products in a new plan to shift its business toward less-harmful products after several failures. 

MO

Read More
1 minute read
  • General
  • Health Care
  • Large Cap
  • News

Juul Is Divested – Altria Now Focuses On Development Efforts For Smoke-Free Products, Updates 2028 Goals

By Vandana Singh
March 24, 11:24 AM
Altria Group Inc (NYSE: MO) unveils a lineup of e-cigarettes, oral nicotine pouches, and other smoke-free products in a new plan to shift its business toward less-harmful products after several failures. 

MO

Read More
4 minute read
  • Biotech
  • Cryptocurrency
  • General
  • Health Care
  • Large Cap
  • Markets
  • Media
  • News
  • Penny Stocks
  • Small Cap
  • Tech
  • Top Stories

Binance Suspends Trading, European Bank Trouble, Twitter To Remove Legacy Verified Checkmarks: Today’s Top Stories

By Vandana Singh
March 24, 9:44 AM
Reuters

AAPL

Read More
1 minute read
  • General
  • Health Care
  • Hedge Funds
  • Large Cap
  • News

Carl Icahn Steps Up Battle With Illumina, Says Directors Asked Additional Insurance For Grail Deal

By Vandana Singh
March 24, 9:18 AM
Activist Carl Icahn reportedly accused Illumina Inc (NASDAQ:ILMN) directors of demanding extra personal liability insurance before agreeing to close the $8 billion…

ILMN

Posts pagination

Previous 1 … 344 345 346 … 437 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service